A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Clinical trial NCT01618669 · COMPLETED
Trial details
- NCT number
- NCT01618669
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.